Summary: ProSomnus Sleep Technologies, a maker of oral appliance therapy for obstructive sleep apnea (OSA), reported record revenues of $9.1 million for Q2 2024, marking a 31% increase over the same period last year and a 22% increase from Q1 2024. The company emerged from … [Read more...]
ProSomnus Posts Q1 Revenue Growth Amid Chapter 11 Filing
Summary: ProSomnus Inc reported a 28% revenue increase for Q1 2024, totaling $7.5 million, despite undergoing Chapter 11 restructuring. The company maintained over 99% on-time delivery rates and continued progress on strategic initiatives. ProSomnus’s RPMO2 Next Generation Remote … [Read more...]
ProSomnus Oral Appliance Research for OSA to be Showcased
Summary: ProSomnus Inc introduced the acceptance of two scientific abstracts for presentation at the 2024 American Academy of Dental Snooze Medication once-a-year conference. The very first analyze displays that precision oral appliance therapy substantially lowers sleep apnea … [Read more...]
ProSomnus Oral Appliances to Be Highlighted in Research
Summary: ProSomnus Inc announced that 4 impartial scientific abstracts employing their precision oral appliances for obstructive slumber apnea (OSA) have been recognized for the 2024 AADSM Yearly Meeting. A person summary gained the Scientific Excellence Award, and a further … [Read more...]
ProSomnus Files for Chapter 11 Bankruptcy for Future Viability
Summary: ProSomnus Sleep Technologies Inc has filed for Chapter 11 bankruptcy as a strategic move to restructure its finances and secure its future. The company plans to reduce its debt by 60% and has arranged approximately $20 million in new financing from existing investors. … [Read more...]
Oral Device Maker ProSomnus Reports Record Revenue for 2023
Summary: ProSomnus Inc, specializing in oral appliance remedy for obstructive slumber apnea, claimed a 43% enhance in 2023 income to $27.7 million, marking its eighth consecutive quarter of history earnings. Development was attributed to the adoption of its EVO item, elevated … [Read more...]